Cesar A Arias Selected Research

Daptomycin

12/2021	Emergence and Transmission of Daptomycin and Vancomycin-Resistant Enterococci Between Patients and Hospital Rooms.
1/2020	Bacteriophage-Antibiotic Combinations for Enterococcus faecium with Varying Bacteriophage and Daptomycin Susceptibilities.
1/2020	Tedizolid as Step-Down Therapy following Daptomycin versus Continuation of Daptomycin against Enterococci and Methicillin- and Vancomycin-Resistant Staphylococcus aureus in a Rat Endocarditis Model.
1/2020	Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an In Vitro Biofilm Model.
5/2019	Novel Strategies for the Management of Vancomycin-Resistant Enterococcal Infections.
1/2019	Disrupting Membrane Adaptation Restores In Vivo Efficacy of Antibiotics Against Multidrug-Resistant Enterococci and Potentiates Killing by Human Neutrophils.
1/2019	Pharmacodynamic Analysis of Daptomycin-treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint.
1/2019	Daptomycin Dose-Ranging Evaluation with Single-Dose versus Multidose Ceftriaxone Combinations against Streptococcus mitis/oralis in an Ex Vivo Simulated Endocarditis Vegetation Model.
1/2019	Efficacy of Tedizolid against Enterococci and Staphylococci, Including cfr+ Strains, in a Mouse Peritonitis Model.
1/2019	LiaR-independent pathways to daptomycin resistance in Enterococcus faecalis reveal a multilayer defense against cell envelope antibiotics.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cesar A Arias Research Topics

Disease

49	Infections 03/2022 - 06/2007
14	Endocarditis 01/2020 - 11/2007
11	Bacteremia 03/2022 - 09/2011
8	Sepsis (Septicemia) 01/2020 - 04/2014
6	Cross Infection (Nosocomial Infection) 01/2022 - 01/2019
5	Peritonitis 01/2021 - 09/2007
5	Body Weight (Weight, Body) 01/2020 - 06/2012
4	COVID-19 12/2021 - 06/2020
2	Bacterial Infections (Bacterial Infection) 01/2022 - 01/2019
2	Respiratory Sounds (Crackle) 01/2022 - 01/2020
2	Critical Illness (Critically Ill) 01/2020 - 09/2015
2	Osteomyelitis 01/2020 - 06/2012
2	Leukemia 01/2018 - 01/2017
1	Neutropenia 03/2022
1	Clostridium Infections 01/2022
1	Diarrhea 01/2022
1	Communicable Diseases (Infectious Diseases) 06/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021
1	Paresthesia (Dysesthesia) 01/2020
1	Coinfection 01/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 10/2019
1	Ventilator-Associated Pneumonia 10/2019
1	Whooping Cough (Pertussis) 01/2019
1	Abdominal Pain (Pain, Abdominal) 09/2018
1	Vasculitis (Vasculitides) 09/2018
1	Exanthema (Rash) 09/2018
1	Gastrointestinal Hemorrhage (Hematochezia) 09/2018
1	Rhabdomyolysis 01/2018
1	Neoplasms (Cancer) 02/2017
1	Hypersensitivity (Allergy) 01/2017
1	Fever (Fevers) 01/2017
1	Urinary Tract Infections (Urinary Tract Infection) 08/2015
1	Meningoencephalitis 11/2012
1	Carcinogenesis 04/2011
1	Autolysis 10/2010

Drug/Important Bio-Agent (IBA)

24	Daptomycin FDA Link 12/2021 - 11/2007
19	Vancomycin FDA LinkGeneric 03/2022 - 11/2007
18	Anti-Bacterial Agents (Antibiotics)IBA 03/2022 - 06/2007
9	Methicillin (Metin)FDA Link 01/2022 - 09/2013
9	Carbapenems (Carbapenem Antibiotics)IBA 01/2022 - 01/2017
8	Cefazolin (Ancef)FDA LinkGeneric 01/2022 - 09/2013
6	Pharmaceutical PreparationsIBA 01/2022 - 10/2008
6	Ampicillin (Omnipen)FDA LinkGeneric 01/2020 - 11/2007
6	Linezolid (Zyvox)FDA Link 01/2019 - 06/2007
4	Ceftaroline FDA Link 01/2020 - 01/2017
4	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2020 - 01/2017
4	LactamsIBA 01/2019 - 01/2017
3	AminoglycosidesIBA 02/2021 - 04/2012
3	tedizolidIBA 01/2020 - 01/2018
3	Anti-Infective Agents (Microbicides)IBA 12/2017 - 11/2013
2	Penicillins (Penicillin)FDA Link 01/2022 - 01/2020
2	carbapenemaseIBA 01/2022 - 01/2020
2	Cephalosporins (Cephalosporin Antibiotics)IBA 02/2021 - 06/2018
2	Nucleic AcidsIBA 01/2021 - 06/2020
2	AntibodiesIBA 09/2020 - 01/2019
2	Ertapenem (Invanz)FDA Link 01/2020 - 01/2018
2	Adenosine Monophosphate (AMP)IBA 01/2020 - 01/2018
2	tazobactam drug combination ceftolozaneIBA 10/2019 - 01/2017
2	LipopeptidesIBA 01/2019 - 12/2018
2	Nafcillin FDA LinkGeneric 06/2018 - 09/2013
2	Gentamicins (Gentamicin)FDA LinkGeneric 01/2017 - 11/2007
1	ceftolozaneIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 12/2021
1	AntigensIBA 06/2021
1	omadacyclineIBA 01/2021
1	Meropenem (Merrem)FDA LinkGeneric 01/2021
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2020
1	Aztreonam FDA LinkGeneric 01/2020
1	CefiderocolIBA 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	ceftazidime drug combination avibactamIBA 01/2020
1	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2020
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2019
1	Pertussis VaccineIBA 01/2019
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 11/2018
1	Influenza Vaccines (Influenza Vaccine)FDA Link 09/2018
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2018
1	Polymyxins (Polymyxin)IBA 12/2017
1	telavancin FDA Link 01/2017
1	bacitracin AIBA 06/2015
1	beta-Lactamases (beta-Lactamase)IBA 09/2013
1	23S Ribosomal RNAIBA 07/2013
1	Panton-Valentine leukocidinIBA 02/2013
1	N 30IBA 11/2012
1	quinupristin-dalfopristin (Synercid)FDA Link 04/2012
1	oritavancinIBA 04/2012
1	Tigecycline (Tygacil)FDA Link 04/2012
1	TOR Serine-Threonine KinasesIBA 04/2011
1	Peptidoglycan (Murein)IBA 10/2010

Therapy/Procedure

19	Therapeutics 10/2021 - 10/2008
1	Urinary Catheters 03/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Remission Induction 01/2021
1	Precision Medicine 01/2020
1	Mechanical Ventilators (Ventilator) 10/2019
1	Fecal Microbiota Transplantation 05/2019
1	Catheters 06/2018
1	Length of Stay 01/2018
1	Indwelling Catheters (Indwelling Catheter) 01/2017
1	Aftercare (After-Treatment) 09/2011